Rogers, Derek J <br/><br/>
Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.  [electronic resource] 

 -  JAMA otolaryngology-- head & neck surgery  May 2013 
 - 496-501 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>2168-619X 
<br/><br/><label>Standard No.: </label>10.1001/jamaoto.2013.1810  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Bevacizumab<br/>Biopsy, Needle<br/>Chemotherapy, Adjuvant<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant<br/>Injections, Intralesional<br/>Laryngeal Neoplasms--drug therapy<br/>Laryngoscopy--methods<br/>Laser Therapy--methods<br/>Male<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Staging<br/>Papillomavirus Infections--drug therapy<br/>Pilot Projects<br/>Prospective Studies<br/>Quality of Life<br/>Reoperation--statistics & numerical data<br/>Respiratory Tract Infections--drug therapy<br/>Risk Assessment<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome